Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
University of Washington
University of California, San Francisco
Queen Mary University of London
University Health Network, Toronto
M.D. Anderson Cancer Center
Eli Lilly and Company
Mayo Clinic
Duke University
Dana-Farber Cancer Institute
University of Miami
University of Southampton
St. Jude Children's Research Hospital